Posted by Natalie Birrell (PR Consultant),
On 1 September 2016 Withy King LLP merged with Royds LLP. The trading name for the merged firm is Royds Withy King. All content produced prior to this date will remain in the name of the firms pre-merger.
Strategic Plan for Synthetic Biology
George Freeman MP, Minister for Life Sciences has published the UK strategic plan for synthetic biology.
The plan recognises the importance of synthetic biology to the future of the UK economy as one of the UK Governments “Eight Great Technologies” and aims to accelerate the commercial translation of products and services with clear public benefit building off the strength of the UK’s research base.
It focuses on the following five key areas of inter-related importance:
o Accelerating industrialisation and commercialisation;
o Maximising the capability of the innovation pipeline;
o Building an expert workforce;
o Developing A Supportive Business Environment; and
o Building value from national and international partnership.
The plan highlights the recent ranking of the UK as one of the most innovative countries in the world and sets out strong recommendations for building international commercial and academic relationships with organisations in other countries with similar skills.
For more information on legal issues relating to the life sciences sector, please contact Thomas Bjorn.